1. Home
  2. CPRX vs DAN Comparison

CPRX vs DAN Comparison

Compare CPRX & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • DAN
  • Stock Information
  • Founded
  • CPRX 2002
  • DAN 1904
  • Country
  • CPRX United States
  • DAN United States
  • Employees
  • CPRX N/A
  • DAN N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • DAN Auto Parts:O.E.M.
  • Sector
  • CPRX Health Care
  • DAN Consumer Discretionary
  • Exchange
  • CPRX Nasdaq
  • DAN Nasdaq
  • Market Cap
  • CPRX 2.9B
  • DAN 2.5B
  • IPO Year
  • CPRX 2006
  • DAN N/A
  • Fundamental
  • Price
  • CPRX $21.81
  • DAN $16.96
  • Analyst Decision
  • CPRX Strong Buy
  • DAN Buy
  • Analyst Count
  • CPRX 6
  • DAN 7
  • Target Price
  • CPRX $32.83
  • DAN $20.00
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • DAN 2.8M
  • Earning Date
  • CPRX 08-06-2025
  • DAN 07-30-2025
  • Dividend Yield
  • CPRX N/A
  • DAN 2.37%
  • EPS Growth
  • CPRX 178.13
  • DAN N/A
  • EPS
  • CPRX 1.57
  • DAN N/A
  • Revenue
  • CPRX $534,645,999.00
  • DAN $9,901,000,000.00
  • Revenue This Year
  • CPRX $16.37
  • DAN N/A
  • Revenue Next Year
  • CPRX $8.80
  • DAN $0.61
  • P/E Ratio
  • CPRX $13.93
  • DAN N/A
  • Revenue Growth
  • CPRX 29.97
  • DAN N/A
  • 52 Week Low
  • CPRX $15.34
  • DAN $7.58
  • 52 Week High
  • CPRX $26.58
  • DAN $18.05
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 42.36
  • DAN 48.95
  • Support Level
  • CPRX $20.62
  • DAN $17.03
  • Resistance Level
  • CPRX $22.06
  • DAN $17.61
  • Average True Range (ATR)
  • CPRX 0.66
  • DAN 0.49
  • MACD
  • CPRX 0.03
  • DAN -0.11
  • Stochastic Oscillator
  • CPRX 56.67
  • DAN 24.83

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Share on Social Networks: